 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

For the last three days, A.I.dvisor has detected that ICVX's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Icosavax (ICVX, $8.22) Aroon Indicator entered a Downtrend on September 18, 2023.

Icosavax (ICVX, $7.45) Aroon Indicator entered a Downtrend on September 15, 2023.

For the last three days, A.I.dvisor has detected that ICVX's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong downtrend ahead for ICVX, and traders may view it as a Sell signal for the next month. Traders may consider ...

Icosavax (ICVX, $8.02) Aroon Indicator entered a Downtrend on August 28, 2023.

Icosavax (ICVX, $7.96) Aroon Indicator entered a Downtrend on August 24, 2023.

Icosavax (ICVX, $7.79) Aroon Indicator entered a Downtrend on August 22, 2023.

Icosavax, Inc. (NASDAQ:ICVX Free Report) William Blair increased their Q3 2023 earnings estimates for shares of Icosavax in a note issued to investors on Tuesday, August 15th. William Blair analyst A. Hsieh now forecasts that the company will earn ($0.60) per share for the quarter, up from their ...

Brokers Issue Forecasts for Icosavax, Inc.'s Q3 2023 Earnings (NASDAQ:ICVX)

Icosavax (ICVX, $7.37) Aroon Indicator entered a Downtrend on August 18, 2023.

Icosavax (ICVX, $7.29) Aroon Indicator entered a Downtrend on August 16, 2023.

Icosavax (ICVX, $7.7) Aroon Indicator entered a Downtrend on August 15, 2023.

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Icosavax reports Q2 EPS (59c), consensus (60c)

Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA.

Watchers	567
52-Wk Low	$2.28
52-Wk High	$16.45

Market Cap	$387.86M
Volume (M)	326,103.00
52-Wk High	$16.45
52-Wk Low	$2.28

ICVX Icosavax Inc

About

Feed

News

Sentiment

Earnings

Fundamentals